- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07270224
Motor Imagery, Hand Mental Rotation, and Performance in Female Volleyball Players
December 19, 2025 updated by: Ayse Yazgan, Medipol University
Motor Imagery Ability, Hand Mental Rotation and Performance Outcomes in Female Volleyball Players: A Comparative Cross-sectional Study
This comparative cross-sectional study investigates the relationship between motor imagery (MI) ability, hand mental rotation (HMR), and performance outcomes in female volleyball players.
Volleyball is a high-speed, cognitively demanding sport requiring precise motor coordination, rapid decision-making, and explosive movements.
MI-the mental simulation of movement-and HMR-the cognitive manipulation of hand orientation-are critical for motor planning and execution.
The study has two primary objectives: (1) to compare MI ability and HMR performance between female volleyball players and sedentary controls, and (2) to evaluate associations between MI/HMR scores and reaction time as well as vertical jump performance among volleyball players.
The investigators hypothesize that volleyball players will exhibit superior MI and HMR abilities compared to controls, and that higher MI and HMR scores will correlate with faster reaction times and greater vertical jump height.
Findings from this study will elucidate the cognitive-motor mechanisms underlying athletic performance and may inform training strategies to enhance neuromotor efficiency in sport-specific contexts.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
52
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beykoz
-
Istanbul, Beykoz, Turkey (Türkiye), 34158
- İstanbul Medipol University
-
-
Istanbul
-
Bakırköy, Istanbul, Turkey (Türkiye), 34158
- Ayşe Yazgan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
The study population consists of licensed female volleyball players competing in regional leagues and healthy female adults with no history of professional sports participation.
Description
Inclusion Criteria: Volleyball Group
- Female participants aged 18-25 years
- Licensed professional volleyball players competing in national or regional leagues
- Currently playing an official main or secondary position
- Minimum of 5 years of professional volleyball experience
- Actively competing in volleyball for at least 1 year
- Training more than 10 hours per week
- No injury in the past 6 months that prevented participation in training or matches
- Ability and willingness to participate voluntarily
- Provided written informed consent
Inclusion Criteria: Control Group
- Female participants aged 18-25 years
- No history of participation in professional or recreational overhead sports
- No lower extremity injury within the past 6 months
- Less than 1 hour per week of structured exercise within the past 6 months
- No previous licensed sports participation
- Provided written informed consent
Exclusion Criteria (Applied to Both Groups)
- Neurological, orthopedic, or systemic diseases
- History of lower extremity injury in the past 6 months
- Any pain, pathology, or instability affecting the upper or lower extremities
- Regular medication use
- Visual or hearing impairments
- Diagnosed cognitive or attention disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Female Volleyball Players
Female athletes currently participating in competitive volleyball; no intervention applied.
|
|
Controls Group
Female individuals not engaged in regular physical activity; no intervention applied.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mental Chronometry Test
Time Frame: Baseline (single assessment during the initial study visit)
|
Mental chronometry ratio calculated as |Actual Time - Imagined Time| / Actual Time, measured during five actual vertical jumps and five imagined vertical jumps.
Lower values indicate better motor imagery performance.
Time measured in seconds using a stopwatch; ratio is unitless.
|
Baseline (single assessment during the initial study visit)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hand Mental Rotation Task
Time Frame: Baseline
|
Mean response time (milliseconds) for left/right hand discrimination tasks in the Orientate® application.
Lower values indicate faster cognitive processing related to mental rotation.
|
Baseline
|
|
Reaction Time (ms)
Time Frame: Baseline
|
Mean reaction time across three trials measured using the BlazePod® wireless LED sensor system.
Participants respond to visual stimuli with their dominant hand.
Lower values indicate better reaction performance.
|
Baseline
|
|
Vertical Jump Height (cm)
Time Frame: Baseline
|
Mean jump height calculated from three countermovement jumps recorded and analyzed using the My Jump 2 smartphone application.
Higher values indicate better lower-limb explosive performance.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ayşe Yazgan, Medipol University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 10, 2025
Primary Completion (Actual)
November 25, 2025
Study Completion (Actual)
December 10, 2025
Study Registration Dates
First Submitted
November 25, 2025
First Submitted That Met QC Criteria
November 25, 2025
First Posted (Estimated)
December 8, 2025
Study Record Updates
Last Update Posted (Actual)
December 26, 2025
Last Update Submitted That Met QC Criteria
December 19, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- MedipolU-OP-AY-03
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reaction Time
-
Medical University of South CarolinaAttune Neurosciences Inc; Nano-Bio Materials ConsortiumWithdrawn
-
Istanbul Medipol University HospitalCompleted
-
Sport University of TiranaCompleted
-
Lindenwood UniversityCompletedCognition | Reaction Time | Energy ExpenditureUnited States
-
University of BaselCompletedMuscle Strength | Endurance Performance | Reaction TimeSwitzerland
-
USANA Health SciencesU.S. Ski & SnowboardCompletedReaction TimeUnited States
-
Kirsehir Ahi Evran UniversitesiCompletedReaction Time | Passive Joint Mobilization | Immediate EffectTurkey
-
Institut National de la Santé Et de la Recherche...CompletedReaction Time | Awareness | Change in Sustained AttentionFrance
-
Balikesir UniversityCompletedCognitive Function | Reaction Time | Balance | E-sports PerformanceTurkey (Türkiye)